INS and metabolic dysfunction-associated steatotic liver disease: The contemporary approach to the pathogenesis of MASLD relies on a multiple-hit hypothesis, according to which MASLD development is triggered by obesity-induced dyslipidemia and lipotoxicity, insulin resistance, mitochondrial dysfunction, oxidative stress, and inflammation [3,4].